| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromatin | 21 | 2023 | 588 | 5.280 |
Why?
|
| Embryonic Stem Cells | 14 | 2023 | 150 | 3.680 |
Why?
|
| Mouse Embryonic Stem Cells | 6 | 2021 | 22 | 2.670 |
Why?
|
| Chromatin Assembly and Disassembly | 12 | 2023 | 229 | 2.540 |
Why?
|
| DNA-Binding Proteins | 11 | 2019 | 1124 | 2.250 |
Why?
|
| Nucleosomes | 9 | 2015 | 185 | 2.030 |
Why?
|
| Transcription Factors | 14 | 2023 | 1447 | 1.810 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2020 | 629 | 1.800 |
Why?
|
| Histones | 15 | 2023 | 460 | 1.630 |
Why?
|
| Lysine Acetyltransferase 5 | 5 | 2018 | 11 | 1.540 |
Why?
|
| Cell Differentiation | 11 | 2023 | 1288 | 1.540 |
Why?
|
| Trans-Activators | 5 | 2018 | 294 | 1.260 |
Why?
|
| Histone Acetyltransferases | 4 | 2015 | 55 | 1.190 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 3 | 2017 | 17 | 1.100 |
Why?
|
| Genome | 4 | 2022 | 251 | 1.100 |
Why?
|
| Histone Code | 3 | 2023 | 25 | 1.060 |
Why?
|
| DNA | 6 | 2019 | 783 | 1.020 |
Why?
|
| Adenosine Triphosphatases | 5 | 2010 | 244 | 0.900 |
Why?
|
| Mice | 24 | 2023 | 10144 | 0.900 |
Why?
|
| Pluripotent Stem Cells | 3 | 2017 | 67 | 0.870 |
Why?
|
| Animals | 32 | 2023 | 19416 | 0.840 |
Why?
|
| Gene Regulatory Networks | 3 | 2022 | 138 | 0.830 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 55 | 0.740 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 75 | 0.740 |
Why?
|
| Promoter Regions, Genetic | 7 | 2022 | 651 | 0.720 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2023 | 418 | 0.690 |
Why?
|
| Chromosome Mapping | 5 | 2022 | 292 | 0.630 |
Why?
|
| Blastocyst | 1 | 2019 | 75 | 0.620 |
Why?
|
| Organogenesis | 1 | 2018 | 40 | 0.620 |
Why?
|
| Molecular Biology | 1 | 2019 | 66 | 0.610 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 347 | 0.600 |
Why?
|
| Stem Cells | 1 | 2020 | 253 | 0.590 |
Why?
|
| Alternative Splicing | 1 | 2018 | 121 | 0.590 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 145 | 0.590 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 691 | 0.580 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 12 | 0.580 |
Why?
|
| RNA | 2 | 2021 | 400 | 0.570 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 379 | 0.550 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 760 | 0.520 |
Why?
|
| Histone Deacetylases | 3 | 2013 | 61 | 0.500 |
Why?
|
| DNA Restriction Enzymes | 1 | 2014 | 35 | 0.480 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 101 | 0.460 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2014 | 249 | 0.460 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2023 | 527 | 0.450 |
Why?
|
| Protein Binding | 7 | 2019 | 1540 | 0.440 |
Why?
|
| Embryo, Mammalian | 4 | 2022 | 161 | 0.400 |
Why?
|
| Cytosine | 1 | 2011 | 30 | 0.390 |
Why?
|
| Proteins | 1 | 2017 | 740 | 0.380 |
Why?
|
| Calcium Channels | 2 | 2008 | 95 | 0.380 |
Why?
|
| Cell Proliferation | 4 | 2020 | 932 | 0.370 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2018 | 316 | 0.360 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1460 | 0.350 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 3 | 2017 | 39 | 0.350 |
Why?
|
| Interphase | 1 | 2010 | 66 | 0.340 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 148 | 0.320 |
Why?
|
| Mitosis | 2 | 2010 | 207 | 0.320 |
Why?
|
| Binding Sites | 4 | 2019 | 870 | 0.320 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2085 | 0.300 |
Why?
|
| Spermatozoa | 2 | 2023 | 248 | 0.290 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 140 | 0.290 |
Why?
|
| RNA Polymerase II | 2 | 2021 | 70 | 0.290 |
Why?
|
| Protein Isoforms | 2 | 2018 | 192 | 0.290 |
Why?
|
| DNA Methylation | 3 | 2018 | 268 | 0.270 |
Why?
|
| Primary Cell Culture | 2 | 2016 | 74 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1534 | 0.240 |
Why?
|
| 5-Methylcytosine | 2 | 2016 | 20 | 0.240 |
Why?
|
| Mutation | 5 | 2018 | 2417 | 0.240 |
Why?
|
| DNA Repeat Expansion | 1 | 2024 | 53 | 0.230 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2001 | 122 | 0.230 |
Why?
|
| C9orf72 Protein | 1 | 2024 | 98 | 0.220 |
Why?
|
| Fibroblasts | 2 | 2018 | 366 | 0.210 |
Why?
|
| Quorum Sensing | 1 | 2023 | 8 | 0.210 |
Why?
|
| X Chromosome Inactivation | 2 | 2017 | 56 | 0.210 |
Why?
|
| S-Adenosylmethionine | 1 | 2023 | 29 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2021 | 144 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 130 | 0.210 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2023 | 42 | 0.210 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 126 | 0.210 |
Why?
|
| Yeasts | 2 | 2004 | 51 | 0.210 |
Why?
|
| Transcription Factor TFIID | 1 | 2022 | 10 | 0.200 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2022 | 17 | 0.200 |
Why?
|
| Oogenesis | 1 | 2022 | 44 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 113 | 0.200 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2022 | 180 | 0.200 |
Why?
|
| DNA Helicases | 2 | 2015 | 184 | 0.190 |
Why?
|
| Epigenomics | 1 | 2021 | 54 | 0.190 |
Why?
|
| Cluster Analysis | 1 | 2021 | 248 | 0.180 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 85 | 0.180 |
Why?
|
| Humans | 13 | 2024 | 58963 | 0.180 |
Why?
|
| Acetylation | 2 | 2012 | 110 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2018 | 15 | 0.180 |
Why?
|
| Epitopes | 1 | 2021 | 298 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 190 | 0.180 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 843 | 0.180 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 320 | 0.170 |
Why?
|
| Proteomics | 1 | 2021 | 251 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2018 | 255 | 0.170 |
Why?
|
| Transcriptome | 1 | 2022 | 317 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 47 | 0.160 |
Why?
|
| Copper | 1 | 2019 | 49 | 0.160 |
Why?
|
| Muscle Development | 1 | 2019 | 53 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2024 | 473 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 375 | 0.160 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 1576 | 0.160 |
Why?
|
| Myoblasts | 1 | 2019 | 63 | 0.160 |
Why?
|
| Neural Tube | 1 | 2018 | 11 | 0.160 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1091 | 0.160 |
Why?
|
| Homozygote | 1 | 2018 | 116 | 0.160 |
Why?
|
| Genetic Loci | 1 | 2018 | 106 | 0.150 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1969 | 0.150 |
Why?
|
| Neisseria meningitidis | 1 | 2018 | 104 | 0.150 |
Why?
|
| Embryoid Bodies | 1 | 2017 | 9 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2022 | 1968 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2017 | 7 | 0.150 |
Why?
|
| Smad3 Protein | 1 | 2017 | 18 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 40 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2018 | 136 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 44 | 0.140 |
Why?
|
| Mixed Function Oxygenases | 1 | 2017 | 17 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 87 | 0.140 |
Why?
|
| Mesoderm | 1 | 2017 | 83 | 0.140 |
Why?
|
| Vitamin B 12 | 1 | 1996 | 25 | 0.140 |
Why?
|
| Endoderm | 1 | 2017 | 51 | 0.140 |
Why?
|
| Methyltransferases | 1 | 1996 | 45 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 197 | 0.140 |
Why?
|
| Hypercholesterolemia | 1 | 2017 | 68 | 0.140 |
Why?
|
| Wound Healing | 1 | 2018 | 177 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 134 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2017 | 289 | 0.140 |
Why?
|
| Base Pairing | 1 | 2016 | 36 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 275 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 1996 | 79 | 0.130 |
Why?
|
| Methylation | 1 | 2016 | 121 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 206 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2016 | 2857 | 0.130 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Protein Footprinting | 1 | 2015 | 4 | 0.130 |
Why?
|
| Phenotype | 3 | 2010 | 1150 | 0.130 |
Why?
|
| RNA Interference | 2 | 2010 | 584 | 0.130 |
Why?
|
| CpG Islands | 1 | 2016 | 212 | 0.130 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 30 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 321 | 0.120 |
Why?
|
| Gene Editing | 1 | 2018 | 278 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2023 | 857 | 0.120 |
Why?
|
| Cell Line | 2 | 2017 | 2010 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 389 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2017 | 246 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2018 | 616 | 0.120 |
Why?
|
| Histone Deacetylase 6 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 261 | 0.110 |
Why?
|
| Macromolecular Substances | 3 | 2003 | 159 | 0.110 |
Why?
|
| Dimerization | 1 | 2013 | 145 | 0.110 |
Why?
|
| Repressor Proteins | 3 | 2014 | 331 | 0.110 |
Why?
|
| Macrophages | 1 | 2018 | 993 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2015 | 732 | 0.100 |
Why?
|
| Meiosis | 2 | 2022 | 62 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 671 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2002 | 288 | 0.090 |
Why?
|
| Metaphase | 1 | 2010 | 35 | 0.090 |
Why?
|
| Anaphase | 1 | 2010 | 33 | 0.090 |
Why?
|
| Serine | 1 | 2010 | 82 | 0.090 |
Why?
|
| Genes, Developmental | 1 | 2008 | 5 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1179 | 0.080 |
Why?
|
| Nanog Homeobox Protein | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cell Survival | 1 | 2010 | 546 | 0.080 |
Why?
|
| DNA Damage | 1 | 2010 | 271 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 298 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 660 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 31 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 254 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2023 | 1348 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2018 | 274 | 0.060 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2005 | 1 | 0.060 |
Why?
|
| Salmonella enterica | 1 | 2005 | 16 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 687 | 0.060 |
Why?
|
| Apoptosis | 1 | 2010 | 1029 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 376 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2023 | 257 | 0.060 |
Why?
|
| Telomere-Binding Proteins | 1 | 2003 | 6 | 0.060 |
Why?
|
| Micrococcal Nuclease | 1 | 2003 | 12 | 0.060 |
Why?
|
| Female | 3 | 2022 | 30656 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 3142 | 0.060 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2003 | 4 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 1133 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2023 | 14 | 0.050 |
Why?
|
| Biochemistry | 1 | 2004 | 50 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 34 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2024 | 206 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 117 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 141 | 0.050 |
Why?
|
| Methionine | 2 | 2005 | 56 | 0.050 |
Why?
|
| X Chromosome | 1 | 2022 | 44 | 0.050 |
Why?
|
| Deoxyribonuclease I | 1 | 2001 | 38 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2001 | 39 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 96 | 0.050 |
Why?
|
| Oocytes | 1 | 2022 | 189 | 0.040 |
Why?
|
| DNA Repair | 1 | 2022 | 225 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 441 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2019 | 43 | 0.040 |
Why?
|
| Gene Expression | 1 | 2023 | 805 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 61 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2017 | 103 | 0.040 |
Why?
|
| Natural Killer T-Cells | 1 | 2017 | 22 | 0.040 |
Why?
|
| Sulfites | 1 | 1996 | 7 | 0.040 |
Why?
|
| Operon | 1 | 1996 | 31 | 0.040 |
Why?
|
| Heme | 1 | 1996 | 27 | 0.040 |
Why?
|
| Cobalt | 1 | 1996 | 16 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 54 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 176 | 0.030 |
Why?
|
| Culture Media | 1 | 1996 | 77 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 174 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 127 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 613 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 162 | 0.030 |
Why?
|
| Cysteine | 1 | 1996 | 107 | 0.030 |
Why?
|
| Iron | 1 | 1996 | 141 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1996 | 299 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2017 | 113 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 2014 | 16 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2014 | 40 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 735 | 0.030 |
Why?
|
| Male | 2 | 2023 | 27322 | 0.020 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Homoserine O-Succinyltransferase | 1 | 2005 | 1 | 0.020 |
Why?
|
| Sigma Factor | 1 | 2005 | 4 | 0.020 |
Why?
|
| Polyphosphates | 1 | 2005 | 12 | 0.020 |
Why?
|
| Acids | 1 | 2005 | 14 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2005 | 44 | 0.020 |
Why?
|
| Acyltransferases | 1 | 2005 | 32 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2005 | 65 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 73 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2005 | 92 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 381 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 115 | 0.010 |
Why?
|
| Dialysis | 1 | 2004 | 6 | 0.010 |
Why?
|
| Salts | 1 | 2004 | 16 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2004 | 23 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 297 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 35 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 252 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 272 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 250 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2003 | 231 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 166 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 728 | 0.010 |
Why?
|
| Nuclease Protection Assays | 1 | 2000 | 3 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 2000 | 54 | 0.010 |
Why?
|
| Response Elements | 1 | 2000 | 42 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 2000 | 56 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2000 | 43 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 2000 | 36 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2000 | 132 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 760 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2000 | 253 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 160 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1111 | 0.010 |
Why?
|
| Software | 1 | 2002 | 357 | 0.010 |
Why?
|
| Algorithms | 1 | 2002 | 984 | 0.010 |
Why?
|